Histone deacetylase inhibitors suppress the expression of inflammatory and innate immune response genes in human microglia and astrocytes

Pathogen Recognition and Innate Immunity

Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,976 · see citing works

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

Minucci, S., & Pelicci, P. G. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1779 · Cited by 2,211 · see citing works

Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation

Chen, L., Fischle, W., Verdin, E. M., & Greene, W. C. (2001) · Science · doi:10.1126/science.1062374 · Cited by 1,231 · see citing works

Toll-like receptor–mediated cytokine production is differentially regulated by glycogen synthase kinase 3

Martin, M., Rehani, K., Jope, R. S., & Michalek, S. M. (2005) · Nature Immunology · doi:10.1038/ni1221 · Cited by 1,080 · see citing works

Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4

Gilchrist, M., Thorsson, V., Li, B., Rust, A., Korb, M., Kennedy, K. A., Hai, T., Bolouri, H., & Aderem, A. (2006) · Nature · doi:10.1038/nature04768 · Cited by 782 · see citing works

Histone deacetylase inhibitors: Potential in cancer therapy

Marks, P. A., & Xu, W. ‐. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22185 · Cited by 716 · see citing works

Discovery and development of SAHA as an anticancer agent

Marks, P. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210204 · Cited by 637 · see citing works

Histone Deacetylase Inhibitors Exhibit Anti-Inflammatory and Neuroprotective Effects in a Rat Permanent Ischemic Model of Stroke: Multiple Mechanisms of Action

Kim, H. J., Rowe, M. K., Ren, M., Hong, J., Chen, P.-S., & Chuang, D. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.120188 · Cited by 557 · see citing works

Post-activation Turn-off of NF-κB-dependent Transcription Is Regulated by Acetylation of p65

Kiernan, R. E., Brès, V., Ng, R. W. M., Coudart, M.-P., Messaoudi, S. E., Sardet, C., Jin, D., Emiliani, S., & Benkirane, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209572200 · Cited by 536 · see citing works

Depletion of latent HIV-1 infection in vivo: a proof-of-concept study

Lehrman, G. K., Hogue, I. B., Palmer, S., Jennings, C., Spina, C. A., Wiegand, A. P., LANDAY, A. L., Coombs, R. W., Richman, D. D., Mellors, J. W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67098-5 · Cited by 511 · see citing works

Prospects: Histone deacetylase inhibitors

Dokmanovic, M., & Marks, P. A. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20532 · Cited by 480 · see citing works

The Histone Deacetylase Inhibitor ITF2357 Reduces Production of Pro-Inflammatory Cytokines In Vitro and Systemic Inflammation In Vivo

Leoni, F., Fossati, G., Lewis, E. C., Lee, J.-K., Porro, G., Pagani, P., Modena, D., Moras, M. L., Pozzi, P., Reznikov, L. L., et al. (2005) · Molecular Medicine · doi:10.2119/2006-00005.dinarello · Cited by 337 · see citing works

Histone deacetylase inhibitors

Monneret, C. (2004) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2004.10.001 · Cited by 337 · see citing works

Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1

Nusinzon, I., & Horvath, C. (2003) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.2433987100 · Cited by 307 · see citing works

Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis.

Camelo, S. I., Iglesias, A. H., Hwang, D., Due, B., Ryu, H., Smith, K., Gray, S., Imitola, J., Durán, G., Assaf, B., et al. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.02.022 · Cited by 281 · see citing works

IL‐1‐regulated responses in astrocytes: Relevance to injury and recovery

John, G. R., Lee, S. C., Song, X., Rivieccio, M. A., & Brosnan, C. F. (2004) · Glia · doi:10.1002/glia.20109 · Cited by 218 · see citing works

Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity

Chang, H.-M., Paulson, M. S., Holko, M., Rice, C. M., Williams, B. R. G., Marié, I., & Levy, D. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400567101 · Cited by 212 · see citing works

Negative Regulation of TLR-Signaling Pathways by Activating Transcription Factor-3

Whitmore, M., Iparraguirre, A., Kubelka, L., Weninger, W., Hai, T., & Williams, B. R. G. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3622 · Cited by 212 · see citing works

MasterCARD: a priceless link to innate immunity

Hiscott, J. B., Lin, R., Nakhaei, P., & Paz, S. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.12.003 · Cited by 192 · see citing works

Requirement of Histone Deacetylase Activity for Signaling by STAT1

Klampfer, L., Huang, J., Swaby, L.-A., & Augenlicht, L. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401359200 · Cited by 187 · see citing works

Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis

Nguyên, T. L.-A., Abdelbary, H., Arguello, M., Breitbach, C. J., Léveillé, S., Diallo, J., Yasmeen, A., Bismar, T. A., Kirn, D. H., Falls, T. J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803988105 · Cited by 183 · see citing works

Glial toll-like receptor signaling in central nervous system infection and autoimmunity

Carpentier, P. A., Duncan, D. S., & Miller, S. D. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.08.011 · Cited by 178 · see citing works

Expression of type II nitric oxide synthase in primary human astrocytes and microglia: role of IL-1beta and IL-1 receptor antagonist

Liu, J., Zhao, M., Brosnan, C. F., & Lee, S. C. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3569 · Cited by 170 · see citing works

Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia

Peng, G.-S., Li, G., Tzeng, N., Chen, P.-S., Chuang, D., Hsu, Y., Yang, S., & Hong, J. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.10.021 · Cited by 170 · see citing works

HIV‐1 Tat‐Mediated Activation of Glycogen Synthase Kinase‐3β Contributes to Tat‐Mediated Neurotoxicity

Maggirwar, S. B., Tong, N., Ramirez, S. H., Gelbard, H. A., & Dewhurst, S. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730578.x · Cited by 164 · see citing works

Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors

Archin, N. M., Keedy, K. S., Espeseth, A. S., Dang, H. K., Hazuda, D. J., & Margolis, D. M. (2009) · AIDS · doi:10.1097/qad.0b013e32832ec1dc · Cited by 162 · see citing works

Characterization of primary human fetal dissociated central nervous system cultures with an emphasis on microglia.

Lee, S. C., Liu, W., Brosnan, C. F., & Dickson, D. W. (1992) · PubMed · Cited by 149 · see citing works

Positive and Negative Regulation of the Innate Antiviral Response and Beta Interferon Gene Expression by Deacetylation

Nusinzon, I., & Horvath, C. M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.3106-3113.2006 · Cited by 139 · see citing works

HDAC inhibitor increases histone H3 acetylation and reduces microglia inflammatory response following traumatic brain injury in rats.

Zhang, B., West, E., Van, K. C., Gurkoff, G. G., Zhou, J., Zhang, X.-M., Kozikowski, A., & Lyeth, B. G. (2008) · Brain Research · doi:10.1016/j.brainres.2008.05.085 · Cited by 138 · see citing works

TLR3 Ligation Activates an Antiviral Response in Human Fetal Astrocytes: A Role for Viperin/cig5

Rivieccio, M. A., Suh, H.-S., Zhao, Y., Zhao, M., Chin, K. C., Lee, S. C., & Brosnan, C. F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4735 · Cited by 135 · see citing works

Deacetylase Activity Is Required for Recruitment of the Basal Transcription Machinery and Transactivation by STAT5

Rascle, A., Johnston, J. A., & Amati, B. B. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.12.4162-4173.2003 · Cited by 131 · see citing works

Histone Deacetylase Activity Is Required to Recruit RNA Polymerase II to the Promoters of Selected Interferon-stimulated Early Response Genes

Sakamoto, S., Potla, R., & Larner, A. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406400200 · Cited by 123 · see citing works

Regulation of microglial inflammatory response by histone deacetylase inhibitors

Suuronen, T., Huuskonen, J., Pihlaja, R., Kyrylenko, S., & Salminen, A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02004.x · Cited by 122 · see citing works

Neuroprotective Activities of Sodium Valproate in a Murine Model of Human Immunodeficiency Virus-1 Encephalitis

Dou, H., Birusingh, K., Faraci, J., Gorantla, S., Poluektova, L. Y., Maggirwar, S. B., Dewhurst, S., Gelbard, H. A., & Gendelman, H. E. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-27-09162.2003 · Cited by 120 · see citing works

Astrocyte Indoleamine 2,3-Dioxygenase Is Induced by the TLR3 Ligand Poly(I:C): Mechanism of Induction and Role in Antiviral Response

Suh, H.-S., Zhao, M., Rivieccio, M. A., Choi, S., Connolly, E. C., Zhao, Y., Takikawa, O., Brosnan, C. F., & Lee, S. C. (2007) · Journal of Virology · doi:10.1128/jvi.00792-07 · Cited by 98 · see citing works

Valproic acid adjunctive therapy for HIV-associated cognitive impairment: A first report

Schifitto, G., Peterson, D. R., Zhong, J., Ni, H., Cruttenden, K., Gaugh, M. D., Gendelman, H. E., Boska, M. D., & Gelbard, H. A. (2006) · Neurology · doi:10.1212/01.wnl.0000204294.28189.03 · Cited by 94 · see citing works

Histone Deacetylase 3, a Class I Histone Deacetylase, Suppresses MAPK11-Mediated Activating Transcription Factor-2 Activation and Represses TNF Gene Expression

Mahlknecht, U., Will, J., Varin, A., Hoelzer, D. F., & Herbein, G. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3979 · Cited by 89 · see citing works

Inhibition of Granulocyte-Macrophage Colony-Stimulating Factor Signaling and Microglial Proliferation by Anti-CD45RO: Role of Hck Tyrosine Kinase and Phosphatidylinositol 3-Kinase/Akt

Suh, H.-S., Kim, M.-O., & Lee, S. C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2712 · Cited by 88 · see citing works

IFNs are critical regulators of IL-1 receptor antagonist and IL-1 expression in human microglia.

Liu, J. S. H., Amaral, T., Brosnan, C., & Lee, S. C. (1998) · Journal of Immunology · doi:10.4049/jimmunol.161.4.1989 · Cited by 84 · see citing works

Lithium therapy for human immunodeficiency virus type 1–associated neurocognitive impairment

Schifitto, G., Zhong, J., Gill, D., Peterson, D. R., Gaugh, M. D., Zhu, T., Tivarus, M. E., Cruttenden, K., Maggirwar, S. B., Gendelman, H. E., et al. (2009) · Journal of NeuroVirology · doi:10.1080/13550280902758973 · Cited by 75 · see citing works

TLR3 and TLR4 are innate antiviral immune receptors in human microglia: Role of IRF3 in modulating antiviral and inflammatory response in the CNS

Suh, H.-S., Zhao, M., Choi, N., Belbin, T. J., Brosnan, C. F., & Lee, S. C. (2009) · Virology · doi:10.1016/j.virol.2009.07.001 · Cited by 73 · see citing works

The Cytokine IL-1β Activates IFN Response Factor 3 in Human Fetal Astrocytes in Culture

Rivieccio, M. A., John, G. R., Song, X., Suh, H.-S., Zhao, Y., Lee, S. C., & Brosnan, C. F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3719 · Cited by 59 · see citing works

Impairment of Interferon-Induced IRF-7 Gene Expression due to Inhibition of ISGF3 Formation by Trichostatin A

Génin, P., Morin, P., & Civas, A. (2003) · Journal of Virology · doi:10.1128/jvi.77.12.7113-7119.2003 · Cited by 53 · see citing works

Toll-Like Receptors in CNS Viral Infections

Suh, H.-S., Brosnan, C. F., & Lee, S. C. (2009) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-00549-7_4 · Cited by 49 · see citing works

Histone deacetylase inhibitors suppress IFNα-induced up-regulation of promyelocytic leukemia protein

Dobrovolná, J., Nováková, Z., Rossmeislová, L., Kahle, M., Hozák, P., & Hodný, Z. (2006) · Blood · doi:10.1182/blood-2006-02-003418 · Cited by 47 · see citing works

Human immunodeficiency virus‐encoded Tat activates glycogen synthase kinase‐3β to antagonize nuclear factor‐κB survival pathway in neurons

Sui, Z., Sniderhan, L. F., Fan, S., Kaźmierczak, K., Reisinger, E., Kovács, A., Potash, M. J., Dewhurst, S., Gelbard, H. A., & Maggirwar, S. B. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04813.x · Cited by 44 · see citing works

Glycogen Synthase Kinase 3 Beta (GSK-3β) as a Therapeutic Target in NeuroAIDS

Dewhurst, S., Maggirwar, S. B., Schifitto, G., Gendelman, H. E., & Gelbard, H. A. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9051-1 · Cited by 42 · see citing works

Effects of ATP and derivatives on neuropile glial cells of the leech central nervous system

M�ller, M., Henrich, A., Klockenhoff, J., Dierkes, P. W., & Schlue, W. R. (2000) · Glia · doi:10.1002/(sici)1098-1136(20000201)29:3 · Cited by 16 · see citing works

Toll-like Receptors: Roles in Infection and Neuropathology

Kielian, T. (2009) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-00549-7 · Cited by 15 · see citing works

Astrocyte Crosstalk in CNS Inflammation

Linnerbauer, M., Wheeler, M. A., & Quintana, F. J. (2020) · Neuron · doi:10.1016/j.neuron.2020.08.012 · Cited by 989 · see citing works

Reactive Astrocytes As Therapeutic Targets for CNS Disorders

Hamby, M. E., & Sofroniew, M. V. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.07.003 · Cited by 367 · see citing works

Microglia: Agents of the CNS Pro-Inflammatory Response

Rodríguez-Gómez, J. A., Kavanagh, E., Engskog-Vlachos, P., Engskog, M. K. R., Herrera, A. J., Espinosa-Oliva, A. M., Joseph, B., Hajji, N., Venero, J. L., & Burguillos, M. A. (2020) · Cells · doi:10.3390/cells9071717 · Cited by 365 · see citing works

Tertiary mechanisms of brain damage: a new hope for treatment of cerebral palsy?

Fleiss, B., & Gressèns, P. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70058-3 · Cited by 367 · see citing works

HDAC inhibitor sodium butyrate-mediated epigenetic regulation enhances neuroprotective function of microglia during ischemic stroke

Patnala, R., Arumugam, T. V., Gupta, N., & Dheen, S. T. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0149-z · Cited by 278 · see citing works

Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus

Christensen, D. P., Dahllöf, M., Lundh, M., Rasmussen, D. N., Nielsen, M. D., Billestrup, N., Grunnet, L. G., & Mandrup-Poulsen, T. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00021 · Cited by 261 · see citing works

Epigenetic targeting of histone deacetylase: Therapeutic potential in Parkinson's disease?

Harrison, I. F., & Dexter, D. T. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.05.010 · Cited by 227 · see citing works

Understanding the role of histone deacetylase and their inhibitors in neurodegenerative disorders: current targets and future perspective

Kumar, V., Kundu, S., Singh, A., & Singh, S. (2022) · Current Neuropharmacology · doi:10.2174/1570159x19666210609160017 · Cited by 210 · see citing works

Epigenetic regulation of astrocyte function in neuroinflammation and neurodegeneration

Neal, M. P., & Richardson, J. R. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.11.004 · Cited by 185 · see citing works

Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation

Kaminska, B., Mota, M., & Pizzi, M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.026 · Cited by 153 · see citing works

Epigenetics Control Microglia Plasticity

Cheray, M., & Joseph, B. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00243 · Cited by 151 · see citing works

Pathological histone acetylation in Parkinson’s disease: Neuroprotection and inhibition of microglial activation through SIRT 2 inhibition

Harrison, I. F., Smith, A. D., & Dexter, D. T. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.12.037 · Cited by 115 · see citing works

Inflammation‐induced sensitization of the brain in term infants

Fleiss, B., Tann, C. J., Degos, V., Sigaut, S., Steenwinckel, J. V., Schang, A., Kichev, A., Robertson, N. J., Mallard, C. E., Hagberg, H., et al. (2015) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.12723 · Cited by 103 · see citing works

Neuroprotective Effect of Sodium Butyrate against Cerebral Ischemia/Reperfusion Injury in Mice

Sun, J., Wang, F., Li, H., Zhang, H., Jin, J., Chen, W., Pang, M., Yu, J., He, Y., Liu, J., et al. (2015) · BioMed Research International · doi:10.1155/2015/395895 · Cited by 95 · see citing works

Neuroprotection by the histone deacetylase inhibitor trichostatin A in a model of lipopolysaccharide-sensitised neonatal hypoxic-ischaemic brain injury

Fleiss, B., Nilsson, M. K. L., Blomgren, K., & Mallard, C. E. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-70 · Cited by 88 · see citing works

Histone Deacetylase Inhibitor Trichostatin A Ameliorated Endotoxin‐Induced Neuroinflammation and Cognitive Dysfunction

Hsing, C., Hung, S., Chen, Y.-C., Wei, T.-S., Sun, D., Wang, J.-J., & Yeh, C. (2015) · Mediators of Inflammation · doi:10.1155/2015/163140 · Cited by 79 · see citing works

Epigenetics and the Modulation of Neuroinflammation

Garden, G. A. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0207-4 · Cited by 70 · see citing works

Regulation of Retinoic Acid Inducible Gene-I (RIG-I) Activation by the Histone Deacetylase 6

Liu, H. M., Jiang, F., Loo, Y., Hsu, S., Hsiang, T.-Y., Marcotrigiano, J., & Gale, M. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.06.015 · Cited by 71 · see citing works

Targeting Histone Deacetylases: A Novel Approach in Parkinson’s Disease

Sharma, S., & Taliyan, R. (2015) · Parkinson s Disease · doi:10.1155/2015/303294 · Cited by 70 · see citing works

Microglial memory of early life stress and inflammation: Susceptibility to neurodegeneration in adulthood

Desplats, P., Gutierrez, A. M., Antonelli, M. C., & Frasch, M. G. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.10.013 · Cited by 70 · see citing works

Inhibition of histone deacetylase 1 or 2 reduces induced cytokine expression in microglia through a protein synthesis independent mechanism

Durham, B. S., Grigg, R., & Wood, I. C. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14144 · Cited by 67 · see citing works

Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results

Berendsen, S., Broekman, M. L. D., Seute, T., Snijders, T. J., van Es, C. A., Vos, F. D., Regli, L., & Robe, P. A. J. T. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.694425 · Cited by 67 · see citing works

The histone deacetylase inhibitor trichostatin A suppresses murine innate allergic inflammation by blocking group 2 innate lymphoid cell (ILC2) activation

Toki, S., Goleniewska, K., Reiss, S., Zhou, W., Newcomb, D. C., Bloodworth, M. H., Stier, M. T., Boyd, K. L., Polosukhin, V. V., Sriram, S., et al. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207728 · Cited by 64 · see citing works

Extracellular Matrix Protein CCN1 Limits Oncolytic Efficacy in Glioma

Haseley, A., Boone, S., Wojton, J., Yu, L., Yoo, J. Y., Yu, J., Kurozumi, K., Glorioso, J. C., Caligiuri, M. A., & Kaur, B. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2526 · Cited by 58 · see citing works

Pharmacological inhibition of Akt and downstream pathways modulates the expression of COX-2 and mPGES-1 in activated microglia

de Oliveira, A. C., Candelario‐Jalil, E., Langbein, J., Wendeburg, L., Bhatia, H. S., Schlachetzki, J. C. M., Biber, K. P. H., & Fiebich, B. L. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-2 · Cited by 58 · see citing works

HDAC Inhibition by Valproic Acid Induces Neuroprotection and Improvement of PD-like Behaviors in LRRK2 R1441G Transgenic Mice

Kim, T., Song, S., Park, Y., Kang, S., & Seo, H. (2019) · Experimental Neurobiology · doi:10.5607/en.2019.28.4.504 · Cited by 58 · see citing works

The analgesic effects of triptolide in the bone cancer pain rats via inhibiting the upregulation of HDACs in spinal glial cells

Hu, X., He, X., Zhou, K.-X., Zhang, C., Zhao, W., Zhang, T., Li, J., Deng, J., & Dong, Y. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0988-1 · Cited by 55 · see citing works

The role of general anesthetics and the mechanisms of hippocampal and extra-hippocampal dysfunctions in the genesis of postoperative cognitive dysfunction

Bimonte, S., & Cascella, M. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.219032 · Cited by 54 · see citing works

Histone deacetylase inhibitors valproic acid and sodium butyrate enhance prostaglandins release in lipopolysaccharide-activated primary microglia

Singh, V., Bhatia, H. S., Kumar, A., de Oliveira, A. C. P., & Fiebich, B. L. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.01.037 · Cited by 53 · see citing works

Butyrate alleviates metabolic impairments and protects pancreatic β cell function in pregnant mice with obesity.

Li, H., Chen, X., & Li, M. (2013) · Europe PMC (PubMed Central) · Cited by 51 · see citing works

Regulator of G Protein Signaling 10 (Rgs10) Expression Is Transcriptionally Silenced in Activated Microglia by Histone Deacetylase Activity

Alqinyah, M., Maganti, N., Ali, M. W., Yadav, R., Gao, M., Çaçan, E., Weng, H., Greer, S. F., & Hooks, S. B. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.106963 · Cited by 50 · see citing works

Dimethyl fumarate regulates histone deacetylase expression in astrocytes

Kalinin, S., Polak, P. E., Lin, S. X., Braun, D. J., Guizzetti, M., Zhang, X., Rubinstein, I., & Feinstein, D. L. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.07.007 · Cited by 50 · see citing works

Histone deacetylase 3 regulates microglial function through histone deacetylation

Meleady, L., Towriss, M., Kim, J. S., Bacarac, V., Dang, V., Rowland, M. E., & Ciernia, A. V. (2023) · Epigenetics · doi:10.1080/15592294.2023.2241008 · Cited by 47 · see citing works

Epigenetic Regulation via Altered Histone Acetylation Results in Suppression of Mast Cell Function and Mast Cell-Mediated Food Allergic Responses

Krajewski, D., Kaczenski, E., Rovatti, J., Polukort, S., Thompson, C., Dollard, C. A., Ser‐Dolansky, J., Schneider, S. S., Kinney, S. R. M., & Mathias, C. B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02414 · Cited by 43 · see citing works

Current Therapies for Neonatal Hypoxic–Ischaemic and Infection-Sensitised Hypoxic–Ischaemic Brain Damage

Tetorou, K., Sisa, C., Iqbal, A., Dhillon, K., & Hristova, M. (2021) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2021.709301 · Cited by 41 · see citing works

Advancements in Hydrazide-Based HDAC Inhibitors: A Review of Recent Developments and Therapeutic Potential

Raucci, A., Zwergel, C., Valente, S., & Mai, A. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01677 · Cited by 45 · see citing works

Valproic acid reduces hair loss and improves survival in patients receiving temozolomide-based radiation therapy for high-grade glioma

Watanabe, S., Kuwabara, Y., Suehiro, S., Yamashita, D., Tanaka, M., Tanaka, A., Ohue, S., & Araki, H. (2016) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-016-2167-1 · Cited by 38 · see citing works

Epigenetics of Neural Repair Following Spinal Cord Injury

York, E. M., Petit, A., & Roskams, A. J. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0228-z · Cited by 37 · see citing works

Epigenetic Regulation Of Axon Regeneration and Glial Activation in Injury Responses

Wahane, S., Halawani, D., Zhou, X., & Zou, H. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00640 · Cited by 36 · see citing works

HDAC1 is Involved in Neuroinflammation and Blood-Brain Barrier Damage in Stroke Pathogenesis

Wang, H., Su, Y.-T., Ho, Y., Lee, Y., Chu, T., Chen, K.-T., & Wu, C. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s416239 · Cited by 34 · see citing works

Death Domain-associated Protein 6 (Daxx) Selectively Represses IL-6 Transcription through Histone Deacetylase 1 (HDAC1)-mediated Histone Deacetylation in Macrophages

Yao, Z., Zhang, Q., Li, X., Zhao, D., Liu, Y., Zhao, K., Liu, Y., Wang, C., Jiang, M., Li, N., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.533992 · Cited by 31 · see citing works

Dual HDAC/BRD4 Inhibitors Relieves Neuropathic Pain by Attenuating Inflammatory Response in Microglia After Spared Nerve Injury

Borgonetti, V., Meacci, E., Pierucci, F., Romanelli, M. N., & Galeotti, N. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01243-6 · Cited by 28 · see citing works

HDACs in the Brain: From Chromatin Remodeling to Neurodegenerative Disease

Diniz, L. P., Pinheiro, P. D. S. M., Franco, L. S., & Gomes, F. C. A. (2025) · Cells · doi:10.3390/cells14171338 · Cited by 26 · see citing works

Histone deacetylase inhibitors up-regulate LL-37 expression independent of toll-like receptor mediated signalling in airway epithelial cells

Liu, Q., Liu, J., Röschmann, K., van Egmond, D., Golebski, K., Fokkens, W. J., Wang, D., & van Drunen, C. M. (2013) · Journal of Inflammation · doi:10.1186/1476-9255-10-15 · Cited by 27 · see citing works

Is there any therapeutic value for the use of histone deacetylase inhibitors for chronic pain?

Wang, W., Cui, S.-S., Lu, R., & Zhang, H. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.04.010 · Cited by 26 · see citing works

Histone Deacetylase Inhibitors Reduce the Number of Herpes Simplex Virus-1 Genomes Initiating Expression in Individual Cells

Shapira, L., Ralph-Altman, M., Tomer, E., Shai, C., & Kobiler, O. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01970 · Cited by 26 · see citing works

Dual BET/HDAC inhibition to relieve neuropathic pain: Recent advances, perspectives, and future opportunities

Romanelli, M. N., Borgonetti, V., & Galeotti, N. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105901 · Cited by 25 · see citing works

Histone deacetylase 6’s function in viral infection, innate immunity, and disease: latest advances

Qu, M., Zhang, H., Cheng, P., Wubshet, A. K., Yin, X., Wang, X., & Sun, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1216548 · Cited by 24 · see citing works

Exploiting tumor epigenetics to improve oncolytic virotherapy

Forbes, N. E., Abdelbary, H., Lupien, M., Bell, J. C., & Diallo, J. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00184 · Cited by 23 · see citing works

Sodium Butyrate as a Histone Deacetylase Inhibitor Affects Toll-Like Receptor 4 Expression in Colorectal Cancer Cell Lines

Kazemi-Sefat, N. A., Mohammadi, M. M., Hadjati, J., Talebi, S., Ajami, M., & Daneshvar, H. (2019) · Immunological Investigations · doi:10.1080/08820139.2019.1595643 · Cited by 23 · see citing works

Role of histone deacetylase inhibitors in non-neoplastic diseases

Zhou, C., Zhao, D., Wu, C., Wu, Z., Zhang, W., Chen, S., Zhao, X., & Wu, S.-L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33997 · Cited by 22 · see citing works

Electroacupuncture improves TBI dysfunction by targeting HDAC overexpression and BDNF-associated Akt/GSK-3β signaling

Hung, S., Chung, H.-Y., Luo, S.-T., Chu, Y.-T., Chen, Y., MacDonald, I. J., Chien, S.-Y., Kotha, P., Yang, L., Hwang, L.-L., et al. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.880267 · Cited by 21 · see citing works

Epigenetic and epitranscriptomic regulation of axon regeneration

Cheng, Y., Song, H., Ming, G., & Weng, Y. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02028-9 · Cited by 20 · see citing works

Toll-Like Signaling and the Cytokine IL-6 Regulate Histone Deacetylase Dependent Neuronal Survival

Forgione, N., & Tropepe, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041033 · Cited by 20 · see citing works

Oncolytic Viruses as a Novel Therapeutic Approach for Colorectal Cancer: Mechanisms, Current Advances, and Future Directions

Pérez-Domínguez, F., Quezada-Monrás, C., Leonardo Cárcamo, G., Muñoz, J. P., & Carrillo-Beltrán, D. (2025) · Cancers · doi:10.3390/cancers17111854 · Cited by 19 · see citing works

HDAC2 Regulates Glial Cell Activation in Ischemic Mouse Retina

Sung, M. S., Heo, H., Eom, G. H., Kim, S. Y., Piao, H., Guo, Y., & Park, S. W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205159 · Cited by 19 · see citing works

Suberanilohydroxamic acid (SAHA), a HDAC inhibitor, suppresses the effect of Treg cells by targeting the c-Myc/CCL1 pathway in glioma stem cells and improves PD-L1 blockade therapy

Sun, T., Liu, B., Cai, L., Zhou, Y., Yang, W., & Li, Y. (2024) · Journal of Neuro-Oncology · doi:10.1007/s11060-024-04689-0 · Cited by 18 · see citing works

Epigenetic regulation of Thy‐1 gene expression by histone modification is involved in lipopolysaccharide‐induced lung fibroblast proliferation

He, Z., Wang, X., Deng, Y., Li, W., Chen, Y., Xing, S., Zhao, X., Ding, J., & Gao, Y. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01659.x · Cited by 18 · see citing works

Histone deacetylase 2 is involved in �‑opioid receptor suppression in the spinal dorsal horn in a rat model of chronic pancreatitis pain

Liao, Y., Wang, J., Wei, Y., Zhang, T., Zhang, Y., Zuo, Z., Teng, X., & Li, Y. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8245 · Cited by 18 · see citing works

Cleavage of HDAC6 to dampen its antiviral activity by nsp5 is a common strategy of swine enteric coronaviruses

Li, Z., Xiao, W., Yang, Z., Guo, J., Zhou, J., Xiao, S., Fang, P., & Fang, L. (2024) · Journal of Virology · doi:10.1128/jvi.01814-23 · Cited by 17 · see citing works

Microglia and Reactive Oxygen Species Are Required for Behavioral Susceptibility to Chronic Social Defeat Stress

Guevara, C. A., Valle, P. D., & Mercedes, C. R. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2175-19.2019 · Cited by 17 · see citing works

Astrocytes and Microglia in Alzheimer's Disease: Friends, Foes, or Both?

Sharma, A., Parekh, B. K., Patil, V., Renuka Jyothi, S., Nayak, P. P., Janney, J. B., Singh, G., & Al-Hasnaawei, S. (2025) · Developmental Neurobiology · doi:10.1002/dneu.23015 · Cited by 17 · see citing works

Valproic acid attenuates nitric oxide and interleukin‑1β production in lipopolysaccharide‑stimulated iron‑rich microglia

Mairuae, N., & Cheepsunthorn, P. (2018) · Biomedical Reports · doi:10.3892/br.2018.1062 · Cited by 15 · see citing works

The histone deacetylase inhibitor valproic acid enhances equine herpesvirus type 1 (EHV-1)-mediated oncolysis of human glioma cells

White, M. C., & Frampton, A. R. (2013) · Cancer Gene Therapy · doi:10.1038/cgt.2012.89 · Cited by 15 · see citing works

Valproic Acid Inhibits Chronic Toxoplasma Infection and Associated Brain Inflammation in Mice

Enshaeieh, M., Saadatnia, G., Babaie, J., Golkar, M., Choopani, S., & Sayyah, M. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01003-21 · Cited by 13 · see citing works

Epigenetic Regulation of Optic Nerve Development, Protection, and Repair

Ashok, A., Pooranawattanakul, S., Tai, W. L., Cho, K., Utheim, T. P., Cestari, D. M., & Chen, D. F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168927 · Cited by 13 · see citing works

Histone Deacetylases in Neurodegenerative Diseases and Their Potential Role as Therapeutic Targets: Shedding Light on Astrocytes

Pinheiro, P. D. S. M., Diniz, L. P., Franco, L. S., Siqueira, M., & Gomes, F. C. A. (2025) · Pharmaceuticals · doi:10.3390/ph18101471 · Cited by 13 · see citing works

The close link between the fetal programming imprinting and neurodegeneration in adulthood: The key role of “hemogenic endothelium” programming

Allegra, A., Giarratana, R. M., Scola, L., & Balistreri, C. R. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111461 · Cited by 12 · see citing works

Short chain fatty acids mediates complement C1q pathway alleviation of perioperative neurocognitive disorders

Liu, X., Tan, X., Yu, Y., Niu, J., Zhao, B., & Wang, Q. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110266 · Cited by 11 · see citing works

Trichostatin A, a Histone Deacetylase Inhibitor, Alleviates Eosinophilic Meningitis Induced by Angiostrongylus cantonensis Infection in Mice

Zhang, Y., Xie, H., Tang, W., Zeng, X., Lin, Y., Xu, L., Xiao, L., Xu, J., Wu, Z., & Yuan, D. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02280 · Cited by 11 · see citing works

Histone Deacetylases Regulation by δ-Opioids in Human Optic Nerve Head Astrocytes.

Zaidi, S. A. H., Thakore, N., Singh, S., Guzman, W., Mehrotra, S., Gangaraju, V., & Husain, S. (2020) · PubMed Central · doi:10.1167/iovs.61.11.17 · Cited by 10 · see citing works

Metabolic Flexibility Assists Reprograming of Central and Peripheral Innate Immunity During Neurodevelopment

Cruz-Carrillo, G., & Camacho‐Morales, A. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02154-3 · Cited by 7 · see citing works

Histone modifications and depression: epigenetic mechanisms, therapeutic targets, and translational outlook

Lv, L.-Z., Wang, Z.-D., Ren, J.-J., Li, L.-H., Liu, X.-B., Li, J.-L., Zhu, H., Jiang, B., Han, Y.-P., Zhou, X.-M., et al. (2026) · Frontiers in Genetics · doi:10.3389/fgene.2025.1722453 · Cited by 7 · see citing works

Activation of toll like receptor-3 induces corneal epithelial barrier dysfunction

Wei, J., Jiang, H., Gao, H., & Wang, G. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.04.080 · Cited by 7 · see citing works

Anti-inflammatory effects of siponimod on astrocytes

Ogasawara, A., Takeuchi, H., Komiya, H., Ogawa, Y., Nishimura, K., Kubota, S., Hashiguchi, S., Takahashi, K., Kunii, M., Tanaka, K., et al. (2022) · Neuroscience Research · doi:10.1016/j.neures.2022.08.003 · Cited by 7 · see citing works

Histone acetylation regulates BMMCs recognition of foot-and-mouth disease virus-like particles

Zhang, J., Han, W., Li, M., Bai, R., Tian, Z., Yuan, W., & Li, L. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110428 · Cited by 6 · see citing works

Trichostatin A Shows Transient Protection from Chronic Alcohol-Induced Reactive Oxygen Species (ROS) Production in Human Monocyte-Derived Dendritic Cells

Parira, T., Figueroa, G., Granado, S., Napuri, J., Castillo-Chabeco, B., Nair, M., & Agudelo, M. (2018) · Journal of Alcoholism and Drug Dependence · doi:10.4172/2329-6488.1000316 · Cited by 5 · see citing works

Histone Deactylase Inhibitors as Novel Target for Cancer, Diabetes, and Inflammation

Singh, P., & Madhavan, T. (2013) · Journal of the Chosun Natural Science · doi:10.13160/ricns.2013.6.1.057 · Cited by 3 · see citing works

Modulation of Histone Deacetylases (HDACs) Expression in Patients with and without Systemic Lupus Erythematosus: Possible Drug Targets for Treatment

Wiley Kenneth, L., Edward, T., Manigaba, K., Word, B. R., Oates, J. R., & Lyn‐Cook, B. D. (2018) · Journal of Rheumatic Diseases and Treatment · doi:10.23937/2469-5726/1510060 · Cited by 2 · see citing works

Valproic acid alleviates total-body irradiation-induced small intestinal mucositis in mice

Kurokawa, Y., Watanabe, S., Yano, T., Izumi, T., Hidaka, N., Yamaguchi, T., & Tanaka, M. (2024) · International Journal of Radiation Biology · doi:10.1080/09553002.2024.2418514 · Cited by 1 · see citing works

Therapeutic Potential of HDAC Inhibitors in Neurodegenerative Diseases

Singh, A. K., Sudhan, Y. G., Chandana, S. L., Iyaswamy, A., & Durairajan, S. S. K. (2026) · Springer eBooks · doi:10.1007/978-981-95-6099-8_14 · Cited by 2 · see citing works

Type 2 diabetes mellitus, drug addiction, bipolar disorder and epilepsy display overlapping aetiopathogenic mechanisms: Implication for prevention and pharmacotherapy

Oriaifo, S. E. (2015) · International Research Journal of Medicine and Medical Sciences · doi:10.14303/jmms.2015.116 · Cited by 1 · see citing works

Histone Deacetylase Inhibitors as Potential COVID-19 Virus RNA-Dependent RNA Polymerase Inhibitors: A Molecular Docking and Dynamics Study

Mohamed, M. F. A., Sayed, A. M., Abdelmohsen, U. R., Nafady, A., Khashaba, P. Y., & Am, H. (2021) · Austin - Critical Care Journal · doi:10.26420/austincritcarej.2021.1036 · Cited by 1 · see citing works

Mechanisms underlying the neuroprotective effects of histone deacetylase inhibitors

Durham, B. S. (2015) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)

Novel mechanisms of regulator of g protein signaling 10 (rgs10) functions in microglia

Alqinyah, M. (2018)

Histone deacetylase inhibitors suppress immune activation in primary mouse microglia

Kannan, V., Brouwer, N., Hanisch, U., Regen, T., Eggen, B. J. L., & Boddeke, H. W. G. M. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23221 · Cited by 105 · see citing works

Inhibition of histone deacetylase 1 or 2 reduces induced cytokine expression in microglia through a protein synthesis independent mechanism

Durham, B. S., Grigg, R., & Wood, I. C. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14144 · Cited by 67 · see citing works

Histone deacetylase (HDAC) inhibitors reduce the glial inflammatory response in vitro and in vivo

Faraco, G., Pittelli, M. G., Cavone, L., Fossati, S., Porcu, M., Mascagni, P., Fossati, G., Moroni, F., & Chiarugi, A. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.019 · Cited by 138 · see citing works

Histone deacetylase 3 regulates microglial function through histone deacetylation

Meleady, L., Towriss, M., Kim, J. S., Bacarac, V., Dang, V., Rowland, M. E., & Ciernia, A. V. (2023) · Epigenetics · doi:10.1080/15592294.2023.2241008 · Cited by 47 · see citing works

Regulation of microglial inflammatory response by histone deacetylase inhibitors

Suuronen, T., Huuskonen, J., Pihlaja, R., Kyrylenko, S., & Salminen, A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02004.x · Cited by 122 · see citing works